(Q40197810)

English

Reduction of hepatic insulin clearance after oral glucose ingestion is not mediated by glucagon-like peptide 1 or gastric inhibitory polypeptide in humans

scientific article published on 3 July 2007

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

Reduction of hepatic insulin clearance after oral glucose ingestion is not mediated by glucagon-like peptide 1 or gastric inhibitory polypeptide in humans (English)

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

1 reference

based on heuristic

inferred from title

Jens Juul Holst

2

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

author name string

Juris J Meier

1

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

Wolfgang E Schmidt

3

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

Michael A Nauck

4

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

publication date

3 July 2007

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

American Journal of Physiology - Endocrinology and Metabolism

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

293

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

E849-56

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

Reduced insulin clearance contributes to the increased insulin levels after administration of glucagon-like peptide 1 in mice

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00289.2007

21 January 2018

The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00289.2007

21 January 2018

Hepatic Removal of Insulin in Normal Man: Dose Response to Endogenous Insulin Secretion*

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00289.2007

21 January 2018

Glucagon-like peptide 1 inhibits cell apoptosis and improves glucose responsiveness of freshly isolated human islets

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00289.2007

21 January 2018

Glucagon-like peptide 1 promotes satiety and suppresses energy intake in humans

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00289.2007

21 January 2018

Relationship between changes in GIP concentrations and changes in insulin and C-peptide concentrations after guar gum therapy

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00289.2007

21 January 2018

The hepatic extraction of gastric inhibitory polypeptide and insulin.

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00289.2007

21 January 2018

Multiple metabolic abnormalities in normal glucose tolerant relatives of NIDDM families.

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00289.2007

21 January 2018

The influence of GLP-1 on glucose-stimulated insulin secretion: effects on beta-cell sensitivity in type 2 and nondiabetic subjects

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00289.2007

21 January 2018

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00289.2007

21 January 2018

The reduction in hepatic insulin clearance after oral glucose is not mediated by gastric inhibitory polypeptide (GIP).

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00289.2007

21 January 2018

Normalization of glucose concentrations and deceleration of gastric emptying after solid meals during intravenous glucagon-like peptide 1 in patients with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00289.2007

21 January 2018

Glucagon-like peptide 1 abolishes the postprandial rise in triglyceride concentrations and lowers levels of non-esterified fatty acids in humans

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00289.2007

21 January 2018

Reduced insulinotropic effect of gastric inhibitory polypeptide in first-degree relatives of patients with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00289.2007

21 January 2018

Secretion, degradation, and elimination of glucagon-like peptide 1 and gastric inhibitory polypeptide in patients with chronic renal insufficiency and healthy control subjects

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00289.2007

21 January 2018

Similar insulin secretory response to a gastric inhibitory polypeptide bolus injection at euglycemia in first-degree relatives of patients with type 2 diabetes and control subjects

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00289.2007

21 January 2018

Pulsatile insulin secretion dictates systemic insulin delivery by regulating hepatic insulin extraction in humans

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00289.2007

21 January 2018

Secretion of incretin hormones (GIP and GLP-1) and incretin effect after oral glucose in first-degree relatives of patients with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00289.2007

21 January 2018

Normalization of fasting hyperglycaemia by exogenous glucagon-like peptide 1 (7-36 amide) in type 2 (non-insulin-dependent) diabetic patients.

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00289.2007

21 January 2018

Insulin secretion, insulin sensitivity, and hepatic insulin extraction in first-degree relatives of type 2 diabetic patients

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00289.2007

21 January 2018

C-Peptide as a Measure of the Secretion and Hepatic Extraction of Insulin: Pitfalls and Limitations

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00289.2007

21 January 2018

Reduced hepatic insulin extraction in response to gastric inhibitory polypeptide compensates for reduced insulin secretion in normal-weight and normal glucose tolerant first-degree relatives of type 2 diabetic patients

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00289.2007

21 January 2018

Direct Assessment of Splanchnic Uptake and Metabolic Effects of Human and Porcine Insulin*

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00289.2007

21 January 2018

Effects of free fatty acids and glycerol on splanchnic glucose metabolism and insulin extraction in nondiabetic humans

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00289.2007

21 January 2018

Insulin secretion and clearance. Comparison after oral and intravenous glucose.

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00289.2007

21 January 2018

Gastric inhibitory polypeptide receptor, a member of the secretin-vasoactive intestinal peptide receptor family, is widely distributed in peripheral organs and the brain

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00289.2007

21 January 2018

Defective amplification of the late phase insulin response to glucose by GIP in obese Type II diabetic patients

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00289.2007

21 January 2018

Discrepancy Between Plasma C-Peptide and Insulin Response to Oral and Intravenous Glucose

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00289.2007

21 January 2018

Both Subcutaneously and Intravenously Administered Glucagon-Like Peptide I Are Rapidly Degraded From the NH2-Terminus in Type II Diabetic Patients and in Healthy Subjects

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00289.2007

21 January 2018

Secretion of Proinsulin C-Peptide by Pancreatic β Cells and its Circulation in Blood

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00289.2007

21 January 2018

Identifiers

10.1152/AJPENDO.00289.2007

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

release_74c6mmexvzbypfxsoszn4whcji

1 reference

https://api.fatcat.wiki/v0/release/74c6mmexvzbypfxsoszn4whcji

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40197810&oldid=1888568921"